Somatostatin Pet as Imaging Biomarker in Neuroblastoma, and Implications for Peptide Receptor Radionuclide Therapy=體抑素接受體正子掃描及肽受體-放射性同位素治療在神經母細胞瘤之臨床應用

Project title

體抑素接受體正子掃描及肽受體-放射性同位素治療在神經母細胞瘤之臨床應用

Internal ID

MOST111-2314-B002-138

Principal Investigator

Start Date

August 1, 2022

End Date

July 31, 2023

Organizations

Partner Organizations

National Science and Technology Council

Project Web Site

https://www.grb.gov.tw/search/planDetail?id=14522230